Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped von Gautier‐Veyret, E, Fonrose, X, Stanke‐Labesque, F

Volltext

Therapeutic Drug Monitoring of Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Patients Who Develop Gastrointestinal Graft-versus-Host Disease von TONINI, J, THIEBAUT, A, JOURDIL, J. F, BERRUYER, A. S, BULABOIS, C. E, CAHN, J. Y, STANKE-LABESQUE, F

Volltext

Cutaneous Iontophoresis of Treprostinil in Systemic Sclerosis: A Proof-of-Concept Study von Roustit, M, Gaillard-Bigot, F, Blaise, S, Stanke-Labesque, F, Cracowski, C, Seinturier, C, Jourdil, J-F, Imbert, B, Carpentier, P H, Cracowski, J-L

Volltext

CYP2C9, SLCO1B1, SLCO1B3, and ABCB11 Polymorphisms in Patients With Bosentan-Induced Liver Toxicity von Roustit, M, Fonrose, X, Montani, D, Girerd, B, Stanke-Labesque, F, Gonnet, N, Humbert, M, Cracowski, J-L

Volltext

Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease von Azad, Abul Kalam, Rauh, Robert, Vermeulen, François, Jaspers, Martine, Korbmacher, Judit, Boissier, Brigitte, Bassinet, Laurence, Fichou, Yann, Georges, Marie des, Stanke, Frauke, De Boeck, Kris, Dupont, Lieven, Balaščáková, Miroslava, Hjelte, Lena, Lebecque, Patrick, Radojkovic, Dragica, Castellani, Carlo, Schwartz, Marianne, Stuhrmann, Manfred, Schwarz, Martin, Skalicka, Veronika, de Monestrol, Isabelle, Girodon, Emmanuelle, Férec, Claude, Claustres, Mireille, Tümmler, Burkhard, Cassiman, Jean-Jacques, Korbmacher, Christoph, Cuppens, Harry

Volltext

Chronic intermittent hypoxia increases infarction in the isolated rat heart von Joyeux-Faure, M, Stanke-Labesque, F, Lefebvre, B, Beguin, P, Godin-Ribuot, D, Ribuot, C, Launois, S. H, Bessard, G, Levy, P

Volltext

Impact of Genetic Polymorphisms in the SCARB1 Gene on Hepatitis C Virus von Westhaus, S, Deest, M, Stanke, F, Heckl, D, Schambach, A, Manns, M.P, Berg, T, Sarrazin, C, Ciesek, S, von Hahn, T

Volltext

Ocfentanil testing in hair from a fatality case: Comparative analysis of a lock of hair versus a single hair fiber von Allibe, N., Paysant, F., Willeman, T., Stanke-Labesque, F., Scolan, V., Eysseric, H.

Volltext

Urinary Leukotriene E4 Concentrations as a Potential Marker of Inflammation in Dogs with Inflammatory Bowel Disease von Im Hof, M., Schnyder, M., Hartnack, S., Stanke‐Labesque, F., Luckschander, N., Burgener, I.A.

Volltext

Anti‐viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy von Deltenre, P., Moreno, C., Tran, A., Ollivier, I., Provôt, F., Stanke, F., Lazrek, M., Castel, H., Canva, V., Louvet, A., Colin, M., Glowacki, F., Dharancy, S., Henrion, J., Hazzan, M., Noel, C., Mathurin, P.

Volltext

138 Dysregulation of epithelial miR-148b contributes to goblet cell metaplasia, inflammation and alveolar damage in cystic fibrosis lung disease von Agrawal, R, Altamura, S, Stanke, F, Meister, M, Muley, T, Randell, S.H, Greene, C.M, Tümmler, B, Muckenthaler, M.U, Mall, M.A

Volltext

P001 TCRß repertoire in monozygotic cystic fibrosis twins von Tümmler, B., Fischer, S., Stanke, F.

Volltext

WS18.05 Linking the compound database CandActCFTR and CFTR lifecycle map to predict possible active compound combinations von Vinhoven, L., Voskamp, M., Stanke, F., Hafekmeyer, S., Nietert, M.M.

Volltext

Diversity of the basic defect of homozygous CFTR mutation genotypes in humans von Stanke, F, Ballmann, M, Bronsveld, I, Dörk, T, Gallati, S, Laabs, U, Derichs, N, Ritzka, M, Posselt, H-G, Harms, H K, Griese, M, Blau, H, Mastella, G, Bijman, J, Veeze, H, Tümmler, B

Volltext

Transient correction of the basic defect in sweat glands in an individual with cystic fibrosis carrying the complex CFTR allele F508del-R553Q von Tümmler, B, Stanke, F, Bronsveld, I, Veeze, H, Ballmann, M

Volltext

P025 Systems biology modelling of CFTR maturation to predict possible active compound combinations von Vinhoven, L., Stanke, F., Hafkemeyer, S., Nietert, M.M.

Volltext

Posaconazole Tablets Versus Posaconazole Oral Suspension in Lung Transplant Patients: Which Consequences on Immunosuppressive Therapy? von Gautier-Veyret, E, Chanoine, S, Pluchart, H, Tonini, J, Fonrose, X, Claustre, J, Bedouch, P, Stanke-Labesque, F

Volltext

ePS3.01 Immunotyping of clinically divergent F508del homozygous monozygous cystic fibrosis twins von Tümmler, B., Hedtfeld, S., Wiehlmann, L., Stanke, F.

Volltext

Expression levels of FAS are regulated through an evolutionary conserved element in intron 2, which modulates cystic fibrosis disease severity von Kumar, V, Becker, T, Jansen, S, van Barneveld, A, Boztug, K, Wölfl, S, Tümmler, B, Stanke, F

Volltext

P027 Comprehensive analysis of chemical structures that have been tested as CFTR-activating substances in a public available database CandActCFTR von Nietert, M.M., Vinhoven, L., Auer, F., Hafkemeyer, S., Stanke, F.

Volltext